Lars Rydén

Karolinska Institutet — Sweden

Medicine · Health Sciences

59h-index20.8kcitations255works14.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(88), Metabolism, Diabetes, and Cancer(51), Cardiovascular Function and Risk Factors(46), Hyperglycemia and glycemic control in critically ill and hospitalized patients(42), Diabetes, Cardiovascular Risks, and Lipoproteins(40)

Publications250 total

Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study
European Journal of Preventive Cardiology·2025· 1 citedOpen Access
Prevalence and prognostic importance of chronic kidney disease in patients with coronary heart disease: results from the combined EUROASPIRE IV and V studies
European Journal of Preventive Cardiology·2025· 1 citedOpen Access
Medications for adults with type 2 diabetes: a living systematic review and network meta-analysis
BMJ·2025· 13 citedOpen Access
Global detection and management of dysglycaemic patients with coronary artery disease results from the INTERASPIRE survey from 14 countries across six WHO regions
Cardiovascular Diabetology·2025· 1 citedOpen Access
International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE study
European Journal of Preventive Cardiology·2025· 7 citedOpen Access
Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease
Journal of the American College of Cardiology·2025· 18 citedOpen Access
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes
Cardiovascular Diabetology·2025· 8 citedOpen Access
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop
Cardiovascular Diabetology·2025· 12 citedOpen Access
Cardiac Rehabilitation in Patients with Coronary Heart Disease – Provision, Attendance, and Outcomes: Results from the INTERASPIRE Survey from Fourteen Countries Across Six WHO Regions
Global Heart·2025· 2 citedOpen Access
Effect of Semaglutide on Kidney Outcomes in People With Overweight or Obesity and Established Cardiovascular Disease in the SELECT Trial
Canadian Journal of Diabetes·2024· 1 cited
Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studies
The Lancet Diabetes & Endocrinology·2024· 7 cited
Does Periodontitis Increase the Risk for Future Cardiovascular Events? Long‐Term Follow‐Up of the <scp>PAROKRANK</scp> Study
Journal Of Clinical Periodontology·2024· 11 citedOpen Access
INTERASPIRE a global cross-sectional survey of secondary prevention of cardiovascular disease (CVD) across six WHO regions
European Journal of Cardiovascular Nursing·2024
Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT
Diabetes Care·2024· 37 citedOpen Access
Semaglutide and Cardiovascular Outcomes by Baseline and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT
2024Open Access
Semaglutide and Cardiovascular Outcomes by Baseline and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT
2024Open Access
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
Nature Medicine·2024· 169 citedOpen Access
#2496 Effect of semaglutide on kidney outcomes in people with overweight or obesity and established cardiovascular disease in the SELECT trial
Nephrology Dialysis Transplantation·2024· 1 citedOpen Access
Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases – Recommendations from the taskforce of the guideline workshop
Diabetes Research and Clinical Practice·2024· 8 cited
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes
Cardiovascular Diabetology·2024· 23 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Guy De Backer(16), David Wood(14), Kornelia Kotseva(13), Dirk De Bacquer(13), Nana Pogosova(12), Linda Mellbin(11), Željko Reiner(11), Anna Norhammar(9), Jeffrey L. Probstfield(8), Arno W. Hoes(8), Oliver Schnell(8), Mátyás Keltai(7), Catriona Jennings(7), Viveca Gyberg(7), Renata Cífková(7), Seppo Lehto(7), Aldo P. Maggioni(7), Gilles R. Dagenais(6), Rafael Díaz(6), Álvaro Avezum(6)